Covid-19: Govt to import 4.5 lakh vials of Remdesivir
HLL Lifecare Ltd, a government of India owned company, has ordered 4,50,000 vials of Remdesivir from M/s Gilead Sciences Inc USA and Egyptian Pharma Company, M/S Eva Pharma, the release said.
New Delhi: The government has placed orders for import of 4.5 lakh vials of antiviral drug Remdesivir with the first consignment of 75,000 vials expected to reach Indian shores on Friday, chemicals and fertilisers ministry said in a statement.
The government has started importing the vital drug Remdesivir from other countries to ease its shortage in the country, the ministry said.
The first consignment of 75,000 vials will reach India on Friday, it added.
Demand for Remdesivir has gone up manifold in the country with a surge in Covid-19 cases. The antiviral drug is used in the treatment of the infectious disease.
HLL Lifecare Ltd, a government of India owned company, has ordered 4,50,000 vials of Remdesivir from M/s Gilead Sciences Inc USA and Egyptian Pharma Company, M/s Eva Pharma, the release said.
It is expected that Gilead Sciences will dispatch 75,000 to 1,00,000 vials in the next one or two days, it noted.
Further, one lakh vials will also be supplied before or by May 15, the release said.
EVA Pharma will supply around 10,000 vials initially followed by 50,000 vials every 15 days or till July, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.